47 Biggest Movers From Yesterday
Gainers
Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share.
Navidea Biopharmaceuticals Announces Research Agreement With The University Of Pennsylvania Evaluating Tc99m Tilmanocept As A Prognostic Marker For Glioblastoma
Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the
Navidea Biopharmaceuticals Announces Settlement Of Platinum Litigation; Receipt Of Noncompliance Notice From NYSE American
Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced settlement
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
Here's a roundup of top developments in the biotech space over the last 24 hours.
Navidea Shares Gain After Terminating Stock Purchase Agreement
Navidea Biopharmaceuticals Inc (NYSE:NAVB) has terminated the Stock Purchase Agreement executed on August 30, 2020. The investors agreed to purchase up…
18 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Wall Street Crime and Punishment: Martin Shkreli, The Self-Destructive Pharma Bro
Does crime pay?
Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition and greed take them in the wrong direction.